Shares of TetraLogic Pharmaceuticals Corp. (TLOG) slumped over 68% in extended trading on Wednesday, following the company’s decision to terminate its phase 2 study of Birinapant in patients suffering from myelodysplastic syndromes.
Forex – financial instrument.Forex news
Shares of TetraLogic Pharmaceuticals Corp. (TLOG) slumped over 68% in extended trading on Wednesday, following the company’s decision to terminate its phase 2 study of Birinapant in patients suffering from myelodysplastic syndromes.